Published in Obstet Gynecol on April 01, 2013
Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccin Immunother (2014) 2.11
Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ (2014) 1.24
Influenza vaccine text message reminders for urban, low-income pregnant women: a randomized controlled trial. Am J Public Health (2013) 1.14
Mind the gap: social media engagement by public health researchers. J Med Internet Res (2014) 1.12
Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage. Hum Vaccin Immunother (2014) 1.07
Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices. Clin Infect Dis (2014) 0.89
Maternal vaccination for the prevention of influenza: current status and hopes for the future. Expert Rev Vaccines (2016) 0.84
Using a Smartphone Application to Promote Healthy Dietary Behaviours and Local Food Consumption. Biomed Res Int (2015) 0.79
The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014. Public Health Rep (2015) 0.79
Improving Influenza and Pneumococcal Vaccination Rates in Ambulatory Specialty Practices. Open Forum Infect Dis (2015) 0.79
Improving rates of maternal immunization: Challenges and opportunities. Hum Vaccin Immunother (2016) 0.77
Impact of Video Education on Influenza Vaccination in Pregnancy. J Reprod Med (2016) 0.75
Brief education to increase uptake of influenza vaccine among pregnant women: a study protocol for a randomized controlled trial. BMC Pregnancy Childbirth (2014) 0.75
Risk management of seasonal influenza during pregnancy: current perspectives. Int J Womens Health (2014) 0.75
Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial. Lancet Glob Health (2017) 0.75
Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center. J Cancer Educ (2017) 0.75
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis (2003) 3.20
Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol (2004) 2.25
Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccin Immunother (2014) 2.11
A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2008) 2.09
Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol (2004) 2.03
Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol (2004) 1.91
Antimicrobial prophylaxis for cesarean delivery before skin incision. Obstet Gynecol (2009) 1.87
Cervical preparation for surgical abortion between 12 and 18 weeks of gestation using vaginal misoprostol and Dilapan-S. Contraception (2010) 1.70
Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol (2004) 1.65
Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol (2005) 1.61
Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis (2005) 1.60
Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis (2003) 1.44
Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis (2003) 1.38
The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2006) 1.35
Influenza immunization in pregnancy: overcoming patient and health care provider barriers. Am J Obstet Gynecol (2012) 1.29
Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol (2004) 1.24
How regular is regular? An analysis of menstrual cycle regularity. Contraception (2004) 1.23
Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol (2008) 1.23
Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol (2003) 1.16
Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol (2010) 1.14
Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am (2008) 1.14
Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis (2007) 1.12
Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis (2009) 1.08
Quantitative survival of aerobic and anaerobic microorganisms in Port-A-Cul and Copan transport systems. J Clin Microbiol (2008) 1.07
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol (2004) 1.05
Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol (2012) 1.01
Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol (2007) 0.99
Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol (2002) 0.98
Acceptance of a pandemic avian influenza vaccine in pregnancy. J Reprod Med (2009) 0.96
Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model. Obstet Gynecol (2009) 0.96
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. J Acquir Immune Defic Syndr (2016) 0.95
Alteration of vaginal elastin metabolism in women with pelvic organ prolapse. Obstet Gynecol (2010) 0.94
Hormones restore biomechanical properties of the vagina and supportive tissues after surgical menopause in young rats. Am J Obstet Gynecol (2008) 0.93
Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women. J Clin Microbiol (2003) 0.93
Plasma versus serum for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies with a glycoprotein G2-based enzyme immunoassay. J Clin Microbiol (2003) 0.92
Adaptations of the rat vagina in pregnancy to accommodate delivery. Obstet Gynecol (2007) 0.92
Episiotomy use among residents and faculty compared with private practitioners. Obstet Gynecol (2004) 0.92
Incidence and epidemiology of Streptococcus pseudoporcinus in the genital tract. J Clin Microbiol (2010) 0.90
Cervicovaginal colposcopic lesions associated with 5 nonoxynol-9 vaginal spermicide formulations. Am J Obstet Gynecol (2008) 0.89
Perceptions and acceptance of immunization during pregnancy. J Reprod Med (2013) 0.89
Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine (2013) 0.87
Comparison of autologous rectus fascia and cadaveric fascia in pubovaginal sling continence outcomes. Am J Obstet Gynecol (2006) 0.87
Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception (2004) 0.86
Vaccine eligibility and acceptance among ambulatory obstetric and gynecologic patients. Vaccine (2011) 0.86
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine (2013) 0.86
Regulation of MMP-1 by sex steroid hormones in fibroblasts derived from the female pelvic floor. Am J Obstet Gynecol (2007) 0.83
Survival of Trichomonas vaginalis in wet preparation and on wet mount. Sex Transm Infect (2013) 0.82
Mifepristone and misoprostol for early pregnancy failure: a cohort analysis. Am J Obstet Gynecol (2011) 0.82
The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod (2008) 0.82
Treatment considerations for bacterial vaginosis and the risk of recurrence. J Womens Health (Larchmt) (2009) 0.81
Patterns of Extragenital Chlamydia and Gonorrhea in Women and Men Who Have Sex With Men Reporting a History of Receptive Anal Intercourse. Sex Transm Dis (2016) 0.80
Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynecol (2006) 0.80
Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis (2005) 0.79
Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment. Contraception (2011) 0.79
Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep (2015) 0.79
Pandemic influenza and pregnancy: an opportunity to reassess maternal bioethics. Am J Public Health (2009) 0.79
The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis (2009) 0.79
Perinatal transmission of Trichomonas vaginalis: a case report. J Reprod Med (2008) 0.79
Update on infectious diseases in adolescent gynecology. J Pediatr Adolesc Gynecol (2008) 0.78
What are patient preferences for follow-up after low-grade cervical intraepithelial neoplasia? J Low Genit Tract Dis (2008) 0.77
Combined hormonal contraception may be protective against Neisseria gonorrhoeae infection. Sex Transm Dis (2010) 0.77
Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause (2009) 0.77
Prophylaxis and treatment of anthrax in pregnant women. Obstet Gynecol (2013) 0.77
Research on vaccines and antimicrobials during pregnancy: challenges and opportunities. Vaccine (2013) 0.76
AN INTERVIEW TOOL TO PREDICT DISRUPTIVE PHYSICIAN BEHAVIOR. Physician Leadersh J (2015) 0.76
Routine pre-cesarean Staphylococcus aureus screening and decolonization: a cost-effectiveness analysis. Am J Manag Care (2011) 0.75
Reply letter regarding terminology in 'Maternal Immunization: Clinical experiences, challenges and opportunities in vaccine acceptance'. Hum Vaccin Immunother (2015) 0.75
Risks Associated With Smallpox Vaccination in Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol (2015) 0.75
Editorial commentary: maternal pertussis vaccination: protecting neonates from infection. Clin Infect Dis (2012) 0.75
Increased expression of matrix metalloproteinases in the uterine cervix of postmenopausal women. J Low Genit Tract Dis (2003) 0.75
Now or later...Does timing of a midurethral sling in relation to transvaginal prolapse repair affect continence outcomes at 1 year? Female Pelvic Med Reconstr Surg (2010) 0.75
A Postpartum Remote Hypertension Monitoring Protocol Implemented at the Hospital Level. Obstet Gynecol (2019) 0.75
Standardizing Maternity Care Data to Improve Coordination of Care. J Obstet Gynecol Neonatal Nurs (2016) 0.75
The Maternal Quality Improvement Program: A Clinical Data-Driven National Registry for Maternity Care. Obstet Gynecol (2017) 0.75
Text Messaging to Improve Preventive Health Attitudes and Behaviors During Pregnancy: A Prospective Cohort Analysis. J Reprod Med (2015) 0.75